ArticlePloS one2025
Navigating Industry 4.0: Leveraging additive technologies for competitive advantage in Colombian aerospace and manufacturing industries.
Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Industry 4.0 initiatives aim to improve competitive advantage. Additive technologies are a technological innovation and have great potential in a developing country like Colombia, The study analyzes how additive technologies, strategies, and process innovation interact to generate positive results, measured by the achievement of operational effectiveness in the aerospace sector and the manufacturing industry in general. Furthermore, the study explores the integration of additive technologies within the framework of Industry 4.0, focusing on the Colombian aerospace and manufacturing sectors. It investigates how these technologies, strategies, and process innovation contribute to operational effectiveness. Data were collected using a Likert-style questionnaire, developed based on established models of innovation framework and operational effectiveness model994 responses were obtained, of which 945 were deemed usable (423 from manufacturing and 522 from aerospace sectors). The analysis involved confirmatory factor analysis (CFA) and structural equation modeling (SEM) using SPSS and AMOS software, ensuring robustness through indicators like Cronbach's Alpha and fit indices. The study compared findings across the two sectors to highlight differences in how additive technologies influence organizational outcomes. Initial results reveal that while additive technologies significantly enhance process innovation across sectors, their direct impact on operational effectiveness is evident only in the aerospace industry. The findings underscore that the aerospace sector benefits from additive technologies due to their need for complex, high-quality, and small-batch production, emphasizing their role in fostering precision and customization. However, the lack of impact in the manufacturing context is attributed to limited strategic alignment and inadequate implementation practices. Moreover, the results indicate that process innovation is a critical mediator, facilitating the translation of technological advancements into improved operational outcomes. Despite moderate correlations between strategies and operational effectiveness in manufacturing, aerospace organizations exhibit more substantial strategic alignment due to stringent performance demands. These findings highlight the importance of fostering a culture of innovation, adapting organizational strategies, and addressing structural challenges to maximize the benefits of additive technologies. The study contributes to understanding the differential adoption of Industry 4.0 technologies in developing economies, with implications for enhancing competitiveness and sustainability in global markets.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.